Cargando…
Diffuse erythematous rash after teneligliptin therapy: A case report
We report a yet unreported, adverse effect of teneligliptin [Dipeptidyl peptidase IV inhibitor (DPP IV)] presenting as diffuse pruritic erythematous rash, in a patient, 2 days after initiation of the drug. The rash waned off after the discontinuation of the drug without any residual lesion.
Autores principales: | Agrawal, Prabhat, Jain, Apoorv, Bansal, Saurabh, Raj, Abhishek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293926/ https://www.ncbi.nlm.nih.gov/pubmed/30613561 http://dx.doi.org/10.4103/jfmpc.jfmpc_283_18 |
Ejemplares similares
-
Tozinameran: Erythematous skin rash with blisters : case report
Publicado: (2022) -
Teneligliptin-induced hair loss: A case report
por: Agrawal, Prabhat K., et al.
Publicado: (2020) -
Erythematous desquamating rash after initiation of chemotherapy
por: Newcomer, Jack, et al.
Publicado: (2023) -
Epidermotropic poorly differentiated adenocarcinoma of colon presenting as a diffuse erythematous petechial rash
por: Sardiña, Luis-Antonio, et al.
Publicado: (2019) -
A Case of Malaria Complicated with Erythematous Rash
por: Ganguli, P., et al.
Publicado: (1936)